353 related articles for article (PubMed ID: 23974779)
1. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
2. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
McFarland MS; Cripps R
Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
9. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
10. Cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment - a clinical appraisal.
Vora J; Ray K; Kosiborod M; Poulter NR; Rajagopalan S; Leiter LA
J Diabetes Complications; 2017 Sep; 31(9):1451-1457. PubMed ID: 28655490
[TBL] [Abstract][Full Text] [Related]
11. Metformin: taking away the candy for cancer?
Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
[TBL] [Abstract][Full Text] [Related]
12. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus: influences on cancer risk.
Szablewski L
Diabetes Metab Res Rev; 2014 Oct; 30(7):543-53. PubMed ID: 25044584
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
15. Glargine safety, diabetes and cancer.
Rendell M; Akturk HK; Tella SH
Expert Opin Drug Saf; 2013 Mar; 12(2):247-63. PubMed ID: 23394441
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
17. Metformin and cancer: licence to heal?
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
19. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.
LeRoith D; Novosyadlyy R; Gallagher EJ; Lann D; Vijayakumar A; Yakar S
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S4-6. PubMed ID: 18777452
[TBL] [Abstract][Full Text] [Related]
20. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
Bailey T
Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
